Roche beefs up diagnostic arm with another bet on faster ... | 合法醫療器材資訊網

2020年5月22日—RochesaiditwillusetheStratostechnology,alongsideitsexistingefforts,todevelopananoporesequencingdevicethatcanquicklyand ...

While Roche pours half a bil­lion dol­lars in­to its Covid-19 an­ti­body test, the Swiss com­pa­ny is qui­et­ly beef­ing up the rest of their di­ag­nos­tics arm.

Roche to­day ac­quired Stratos Ge­nomics, a Seat­tle-based de­vel­op­er of a new DNA tech­nol­o­gy de­signed to make ge­net­ic strands more easy to read. Roche said it will use the Stratos tech­nol­o­gy, along­side its ex­ist­ing ef­forts, to de­vel­op a nanopore se­quenc­ing de­vice that can quick­ly and cheap­ly read pa­tients’ DNA in clin­ics to di­ag­no­sis dis­ease and as­sess the risk of de­vel­op­ing one.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.